Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibacterial Effect of Levobupivacaine on S. Aureus in a PCA Model
NCT07285759Completed
- Sponsor
- Dokuz Eylul University
- Start
- Nov 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
01
Overview
Open-label trial of levobupivacaine in Staphylococcus aureus infection (4 arms), sponsored by Dokuz Eylul University. Primary endpoint: Reduction in Staphylococcus aureus Colony Count at 24 hours. Started Nov 2010; status: completed.
02
Drugs
levobupivacaine
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT07285759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07285759.